Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Postoperative analgesia with intra-articular ropivacaine combined with esketamine or alfentanil after knee arthroscopy
ChiCTR2300069052Phase 4Not yet recruiting
- Sponsor
- Central Hospital of Enshi Tujia and Miao Autonomous Prefecture
- Start
- Apr 2023
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of ropivacaine, esketamine and alfentanil in postoperative pain (3 arms), sponsored by Central Hospital of Enshi Tujia and Miao Autonomous Prefecture. Primary endpoint: Time to first postoperative rescue analgesia. Planned start Apr 2023; status: not yet recruiting.
02
Drugs
ropivacaineesketaminealfentanil
03
Conditions
postoperative pain
Beyond the preview
Go deeper on ChiCTR2300069052.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2300069052.